Is Chronic Pain Undertreated and Underrepresented? An Advocate Says Yes.
The FDA wants to hear from you—but don’t be distracted by the title. A noted chronic pain advocate believes this is an opportunity for chronic pain advocates to comment. The official announcement is that the FDA wants input and comments from stakeholders, including racial and ethnic minority, underrepresented, and underserved populations in establishing strategic priorities … Read more